IMVT EPS Estimates
Immunovant, Inc.
$27.90
-$0.81(-2.82%)
35
Overall
40
Value
36
Tech
31
Quality
Market Cap
$5.76B
Volume
1.77M
52W Range
$16.77 - $45.42
Target Price
$47.72
IMVT EPS estimates: the consensus estimate for Immunovant, Inc.'s current fiscal year is -$2.96 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IMVT EPS Estimates
- EPS estimate, current quarter
- $-0.73
- EPS estimate, next quarter
- $-0.72
- EPS estimate, current year
- $-2.96
- EPS estimate, next year
- $-3.01
- EPS growth, 3-year
- -17.44%
| Fiscal year | EPS |
|---|---|
| 2026 | $-2.77 |
| 2025 | $-2.73 |
| 2024 | $-1.88 |
| 2023 | $-1.71 |
| 2022 | $-1.43 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMVT | $27.90 | -2.8% | 1.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |